Sanaby Health Acquisition Corp. I
SANB
NASDAQ Global Market10.21
USD
- -
- -
CIK
0001856689
ISIN
US79956P1021
CUSIP
79956P102
Return %
Stock
S&P500
1Y
2.51
26.84
3Y
3.44
77.03
5Y
3.44
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 2625 Middlefield Roa Palo Alto CA United States of America 94306
- IPO Date
- Nov 9, 2021
- CIK
- 0001856689
- Similar Companies
- Business
- Sanaby Health Acquisition Corp. I is a blank check company formed primarily to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses operating predominantly in the healthcare industry. The company targets opportunities in digital health, life science tools and services, and innovative therapeutics. Founded in 2021 and headquartered in Palo Alto, California, Sanaby Health Acquisition Corp. I operates with a focus on healthcare-related acquisitions across various geographic regions. The company's main products and services are framed by its business model as a special purpose acquisition company (SPAC), which involves raising capital through an initial public offering to acquire or merge with existing healthcare entities rather than producing or selling healthcare products directly. Sanaby Health Acquisition Corp. I completed its initial public offering in October 2021, raising approximately $172.5 million aimed at healthcare sector acquisitions. In October 2022, Sanaby Health Acquisition Corp. I announced the liquidation of its public shares, electing not to consummate an initial business combination within the prescribed timeframe. This decision led to the dissolution and liquidation of the company as per its amended charter, with proceeds from the trust account returned to shareholders. This marked a significant operational change reflecting an inability to finalize a merger or acquisition within the expected timeline and the consequent strategy to return capital to investors rather than pursue further acquisition activities. There have been no reported subsequent acquisitions, product launches, or strategic shifts following this liquidation announcement. Sanaby Health Acquisition Corp. I is led by healthcare industry veterans, including CEO Sandra Shpilberg, and was initially supported by underwriters such as BTIG, LLC. The company’s key focus remains on identifying promising healthcare opportunities, although as of late 2022 it has ceased acquisition activities and is in the process of liquidation. This description reflects the company's formation as a healthcare-focused SPAC, its IPO activities, and its latest major change—the decision to dissolve and liquidate due to the absence of a business combination within the mandated timeframe. The company does not operate direct healthcare product lines or services but functions as an acquisition vehicle within the healthcare sector. Headquarters is in Palo Alto, California, founded in 2021, with no ongoing business operations following liquidation.